BioCentury
ARTICLE | Company News

Alfacell other research news

July 25, 1994 7:00 AM UTC

In the Proceedings of the National Academy of Sciences, the Bloomfield, N.J., company and colleagues at NIH and in Italy showed that the anti-cancer candidate Onconase stops replication of the AIDS virus in cell culture. However, the company remains focused on its planned Phase III trials of the agent in cancer. ...